Literature DB >> 15477598

IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

SangKon Oh1, Liyanage P Perera, Donald S Burke, Thomas A Waldmann, Jay A Berzofsky.   

Abstract

T cell avidity is critical to viral clearance, but mechanisms of CD8(+) T cell avidity maturation are poorly understood. Here, we find that IL-15 mediates two mechanisms of avidity maturation. (i) By selection at the population level, IL-15 promotes greater survival of high- compared with low-avidity cytotoxic T lymphocytes (CTLs). High-avidity CTLs express higher levels of IL-15Ralpha and persist longer by homeostatic proliferation. (ii) At the individual cell level, IL-15 induces higher levels of surface coreceptor CD8alphabeta, increasing functional avidity. IL-15 during priming selects or induces higher-avidity CTLs. Conversely, high-avidity CTLs are diminished in IL-15Ralpha knockout mice. These results provide an explanation of CD8+ T cell avidity maturation and may contribute to the design of novel vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477598      PMCID: PMC524066          DOI: 10.1073/pnas.0406649101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  T cells down-modulate peptide-MHC complexes on APCs in vivo.

Authors:  Ross M Kedl; Brian C Schaefer; John W Kappler; Philippa Marrack
Journal:  Nat Immunol       Date:  2001-12-03       Impact factor: 25.606

2.  Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity.

Authors:  Andrew G Cawthon; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

3.  Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.

Authors:  V Dutoit; V Rubio-Godoy; P Y Dietrich; A L Quiqueres; V Schnuriger; D Rimoldi; D Liénard; D Speiser; P Guillaume; P Batard; J C Cerottini; P Romero; D Valmori
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

4.  Control of homeostasis of CD8+ memory T cells by opposing cytokines.

Authors:  C C Ku; M Murakami; A Sakamoto; J Kappler; P Marrack
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

5.  Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: correlation with CD8alphabeta versus CD8alphaalpha expression.

Authors:  A G Cawthon; H Lu; M A Alexander-Miller
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

6.  Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.

Authors:  Fernando Rodriguez; Stephanie Harkins; Mark K Slifka; J Lindsay Whitton
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Programmed contraction of CD8(+) T cells after infection.

Authors:  Vladimir P Badovinac; Brandon B Porter; John T Harty
Journal:  Nat Immunol       Date:  2002-06-03       Impact factor: 25.606

8.  Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers.

Authors:  M A Daniels; S C Jameson
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

9.  Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction.

Authors:  R Bosselut; W Zhang; J M Ashe; J L Kopacz; L E Samelson; A Singer
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

10.  Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells.

Authors:  Todd C Becker; E John Wherry; David Boone; Kaja Murali-Krishna; Rustom Antia; Averil Ma; Rafi Ahmed
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  58 in total

1.  Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.

Authors:  Yongjun Sui; Qing Zhu; Susan Gagnon; Amiran Dzutsev; Masaki Terabe; Monica Vaccari; David Venzon; Dennis Klinman; Warren Strober; Brian Kelsall; Genoveffa Franchini; Igor M Belyakov; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.

Authors:  Tod J Merkel; Pin-Yu Perera; Vanessa K Kelly; Anita Verma; Zara N Llewellyn; Thomas A Waldmann; Joseph D Mosca; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 3.  Strategies to use immune modulators in therapeutic vaccines against cancer.

Authors:  Jay A Berzofsky; Masaki Terabe; Lauren V Wood
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

4.  Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.

Authors:  Igor M Belyakov; Vladimir A Kuznetsov; Brian Kelsall; Dennis Klinman; Marcin Moniuszko; Michael Lemon; Phillip D Markham; Ranajit Pal; John D Clements; Mark G Lewis; Warren Strober; Genoveffa Franchini; Jay A Berzofsky
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

5.  Survival adjustment of mature dendritic cells by IL-15.

Authors:  Sigrid P Dubois; Thomas A Waldmann; Jürgen R Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

6.  Latent virus influences the generation and maintenance of CD8+ T cell memory.

Authors:  Brian S Sheridan; Kamal M Khanna; Gregory M Frank; Robert L Hendricks
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

Review 7.  Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?

Authors:  Xavier Clemente-Casares; Sue Tsai; Yang Yang; Pere Santamaria
Journal:  J Mol Med (Berl)       Date:  2011-04-16       Impact factor: 4.599

8.  IL-15 increases the frequency of effector memory CD8+ T cells in rhesus monkeys immunized with HIV vaccine.

Authors:  Shirui Li; Xiangrong Qi; Yingying Gao; Yanling Hao; Lianxian Cui; Li Ruan; Wei He
Journal:  Cell Mol Immunol       Date:  2010-09-27       Impact factor: 11.530

9.  Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

Authors:  Eynav Klechevsky; Maochang Liu; Rimpei Morita; Romain Banchereau; Luann Thompson-Snipes; A Karolina Palucka; Hideki Ueno; Jacques Banchereau
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

10.  Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice.

Authors:  Leo L M Poon; Y H Connie Leung; John M Nicholls; Pin-Yu Perera; Jack H Lichy; Masafumi Yamamoto; Thomas A Waldmann; J S Malik Peiris; Liyanage P Perera
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.